Zobrazeno 71 - 80
of 157
pro vyhledávání: '"35"'
Publikováno v:
Cancer Research. 73:P2-14
Background: The majority of breast cancer cases are considered to be sporadic and occur in women without a strong family history. Accurate estimation of a woman's risk of developing breast cancer is essential for guiding decisions regarding surveilla
Autor:
D van den Bongard, Tobias Lekberg, F van der Leij, P. Elkhuizen, E.J.T. Rutgers, Harry Bartelink, Sofia Rivera
Publikováno v:
Cancer Research. 73:P5-14
Background The ongoing Preoperative Accelerated Partial Breast Irradiation (PAPBI) trial (NCT01024582) was based on the rationale that three-dimensional conformal external-beam radiation (3D-CRT) leads to more dose homogeneity compared with brachy-or
Autor:
Armando E. Giuliano, Karla V. Ballman, M Chadha, J Moni, Thomas A. Buchholz, F Laurie, Reshma Jagsi, Bruce G. Haffty
Publikováno v:
Cancer Research. 73:P5-14
Purpose/Objective: The landmark ACOSOG Z0011 trial established that axillary lymph node dissection (ALND) is unnecessary in breast cancer patients with one or two positive sentinel lymph nodes (SLN) who undergo lumpectomy, radiation therapy (RT) and
Publikováno v:
Cancer Research. 73:P2-18
Background In patients with fine needle aspiration (FNA)-proven axillary lymph node metastasis at diagnosis (cN+), the current standard surgical procedure is axillary lymph node dissection (ALND) at definitive surgery after neoadjuvant chemotherapy (
Autor:
T Stanise, L Reed, K Alexis, M Strakhan, M Matquez, M Castaldi, W Bodner, Richard J. Gralla, A Shaker, T Elrafei
Publikováno v:
Cancer Research. 73:P1-09
Background: Patient navigation has been demonstrated to aid in adherence to breast cancer screening initiatives. Fewer studies have documented benefit for patients undergoing treatment, and especially among those with barriers to care. Cancer health
Publikováno v:
Cancer Research. 75:P1-03
Introduction/background In May 2013, AJ revealed to the media that she had undergone preventive double mastectomy. The actress had a family history of breast and ovarian cancer and tested positive for the BRCA1 gene mutation. Media coverage has been
Publikováno v:
Cancer Research. 72:P3-14
Background: The National ABS Guidelines indicate axillary surgery is unwarranted in DCIS but should be offered to patients undergoing mastectomy. Up to 30% of pre-operatively diagnosed DCIS lesions harbour occult invasive cancers at mastectomy. Metho
Publikováno v:
Cancer Research. 71:P5-12
Aim The enormous increase in the diagnosis of ductal carcinoma in situ (DCIS) by the NHS Breast screening has not lead to an expected decrease in the incidence of invasive breast cancer. It is not clear if all grades of DCIS progress inexorably to in
Autor:
Christopher Lanigan, Erinn Downs-Kelly, Z Wang, Bryce P. Portier, G. T. Budd, Raymond R. Tubbs
Publikováno v:
Cancer Research. 71:P1-07
Background: Clinical testing for HER2 amplification/over-expression is performed by immunohistochemistry (IHC) and/or fluorescence in situ hybridization (FISH) as outlined by the ASCO/CAP guidelines. Although these guidelines standardize testing and
Autor:
Larissa A. Korde, Claudine Isaacs, Philip Cohen, Ann Gallagher, M Gatti, David Venzon, Robert D. Warren, Jennifer Eng-Wong, JoAnne Zujewski
Publikováno v:
Cancer Research. 71:P3-11
Background: Aromatase inhibitors are effective for breast cancer prevention in postmenopausal women. In the recent MAP.3 study, exemestane significantly reduced invasive breast cancer in postmenopausal women with an elevated risk of developing breast